P3 Prostate Cancer Forum: 2024
Session 3 - Mapping the Journey: Strategies and RWE in nmCRPC
In session 3, we gained insights into nmCRPC patients in the UK, and discussed how the treatment paradigm is shifting in this patient group, as next-generation imaging becomes increasingly available and primary treatment choices are changing.
Meeting Summary Downloadable
Download the summary below for the key takeaways from this meeting.
Speakers
Session 4 - Looking ahead: confronting the challenges of mCRPC
In session 4, we took a deep dive into mCRPC, the latest therapies and data and key considerations for treatment sequencing in this patient group
PP-NUB-GB-2017, January 2025